Trexquant Investment LP - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Trexquant Investment LP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2022$624,000
-23.6%
107,192
-21.6%
0.02%
-40.5%
Q2 2022$817,000–136,779–0.04%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q2 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders